Adaptive Biotechnologies CFO Piskel Kyle buys and sells shares on 2026-02-04.

Adaptive Biotechnologies Corporation, a company with the ticker symbol ADPT, has recently disclosed information regarding the actions of its Chief Financial Officer, Kyle Piskel. Specifically, it has been reported that on February 4, 2026, Kyle Piskel purchased 2,145 shares of the company's stock at a price of $12.14 per share. Subsequently, on the same day, he sold an equal number of shares, 2,145, at a price of $18.46 per share.